https://www.selleckchem.com/pr....oducts/pf-05221304.h
Experimental results show that the proposed method achieved outstanding tracking performance and met the actual application requirements.Coxsackieviruses type B are one of the most common causes of mild upper respiratory and gastrointestinal illnesses. At the time of writing, there are no approved drugs for effective antiviral treatment for Coxsackieviruses type B. We used the core-structure of pleconaril, a well-known antienteroviral drug candidate, for the synthesis of novel compounds with O-propyl linker modifications. Some origi
Like
Comment
Share
